NPI: 1598731861 · WASHINGTON, DC 20002 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 02/27/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 02/27/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 48,019 | $746K |
| 2019 | 50,508 | $563K |
| 2020 | 43,718 | $427K |
| 2021 | 42,858 | $284K |
| 2022 | 43,552 | $662K |
| 2023 | 22,796 | $708K |
| 2024 | 9,681 | $660K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 82,518 | 6,058 | $3.68M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 74,811 | 3,668 | $262K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 1,825 | 735 | $55K |
| J1756 | Injection, iron sucrose, 1 mg | 18,265 | 3,583 | $40K |
| J1270 | Injection, doxercalciferol, 1 mcg | 41,701 | 3,465 | $8K |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 4,149 | 668 | $4K |
| 83970 | 4,521 | 3,389 | $1K | |
| 90674 | 200 | 160 | $821.48 | |
| 90747 | 27 | 24 | $751.10 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 2,342 | 1,216 | $666.91 |
| 91320 | 16 | 13 | $393.30 | |
| 82728 | 3,084 | 2,422 | $292.23 | |
| 84466 | 1,844 | 1,254 | $270.90 | |
| 90732 | 29 | 26 | $230.12 | |
| A4657 | Syringe, with or without needle, each | 8,937 | 4,314 | $207.85 |
| 83540 | 3,335 | 2,606 | $147.26 | |
| 85041 | 4,402 | 3,240 | $128.26 | |
| G0008 | Administration of influenza virus vaccine | 318 | 257 | $121.72 |
| 85048 | 4,383 | 3,228 | $107.66 | |
| 82108 | 393 | 314 | $71.63 | |
| 83550 | 1,628 | 1,446 | $67.29 | |
| 0012A | 25 | 25 | $47.10 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 169 | 127 | $42.52 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 1,979 | 386 | $31.74 |
| 0011A | 31 | 23 | $16.94 | |
| 85045 | 35 | 15 | $4.53 | |
| 90480 | 16 | 13 | $0.00 | |
| 90662 | 149 | 119 | $0.00 |